Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Scand J Immunol ; 70(2): 101-5, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19630915

RESUMO

Transfusion of blood may contribute to immunomodulation. Leuco-depleted standard blood products are supposed to result in less immunomodulation compared with whole blood. To determine the influence of leuco-depleted blood products on the cytokine response, red blood cell concentrates (RBC), fresh frozen plasma (FFP) and platelet concentrates (PC) were investigated in an in vitro model of blood transfusion. Leuco-depleted standard blood bank RBC, FFP and PC were mixed in vitro with AB0 compatible venous blood from healthy volunteers in ratios of 3:1, 1:1 and 1:3. Specimens were incubated in presence or absence of lipopolysaccharide, 1 mug/ml. After 24 h of incubation cytokine release of tumour necrosis factor (TNF)-alpha and interleukin-10 (IL-10) was measured in cell culture supernatants by means of enzyme-linked immunsorbent assay. Addition of RBC, FFP and PC to venous blood from healthy volunteers led to a significant and dose-dependent increase in spontaneous TNF-alpha and IL-10 release. After endotoxin stimulation, RBC, FFP and PC significantly suppressed the TNF-alpha response, while the stimulated release of IL-10 tended to increase, reaching significance only after high doses of FFP. Addition of leuco-depleted blood products changed the spontaneous and stimulated cytokine response in an in vitro model of transfusion. These data may suggest a possible contribution of transfused FFP and PC to immunomodulation after transfusion similar to RBC.


Assuntos
Transfusão de Componentes Sanguíneos , Plaquetas/imunologia , Eritrócitos/imunologia , Plasma/imunologia , Plaquetas/metabolismo , Eritrócitos/metabolismo , Humanos , Interleucina-10/agonistas , Interleucina-10/sangue , Lipopolissacarídeos/farmacologia , Modelos Biológicos , Plasma/metabolismo , Fator de Necrose Tumoral alfa/sangue , Fator de Necrose Tumoral alfa/efeitos dos fármacos
2.
Anaesthesist ; 56(3): 232-5, 2007 Mar.
Artigo em Alemão | MEDLINE | ID: mdl-17221261

RESUMO

Due to the high risk of perioperative adverse events, elective surgery should be suspended for at least 4 weeks after myocardial infarction and coronary stent revascularization, as current guidelines suggest. This report describes the successful management of a patient who underwent urgent surgery for a displaced hip fracture immediately after stent revascularization of an acute myocardial infarction. No new perioperative ischemia was detected. The therapeutic options and the timing of surgical procedures after stent revascularization are discussed.


Assuntos
Angioplastia Coronária com Balão , Artroplastia de Quadril , Fraturas do Quadril/complicações , Fraturas do Quadril/cirurgia , Infarto do Miocárdio/complicações , Infarto do Miocárdio/cirurgia , Revascularização Miocárdica , Stents , Doença Aguda , Idoso , Anestesia , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA